logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5150.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5150.produseast1
First Newborn Baby to Receive Experimental Therapies Survives Ebola Virus Disease | Journal Article / Short Report | MSF Science Portal
Journal Article
|Short Report

First Newborn Baby to Receive Experimental Therapies Survives Ebola Virus Disease

Dornemann J, Burzio C, Ronsse A, Sprecher A, De Clerck H, Van Herp M, Kolie MC, Yosifiva V, Caluwaerts C, McElroy AK, Antierens A
Download

Similar Content
Loading...
Loading...
Loading...
Abstract
A neonate born to an Ebola virus-positive woman was diagnosed with Ebola virus infection on her first day of life. The patient was treated with monoclonal antibodies (ZMapp), a buffy coat transfusion from an Ebola survivor, and the broad-spectrum antiviral GS-5734. On day 20, a venous blood specimen tested negative for Ebola virus by quantitative reverse-transcription polymerase chain reaction. The patient was discharged in good health on day 33 of life. Further follow-up consultations showed age-appropriate weight gain and neurodevelopment at the age of 12 months. This patient is the first neonate documented to have survived congenital infection with Ebola virus.

Countries

Guinea

Subject Area

Ebola

Languages

English
DOI
10.1093/infdis/jiw493
Published Date
15 Jan 2017
PubMed ID
28073857
Journal
Journal of Infectious Diseases
Issue Date
2017-01-09
Dimensions Badge